
African-American patients have been zzso in zzso clinical zzso Better understanding barriers to African-American participation may help increase the zzso of African-American patients onto clinical zzso 

Two hundred zzso patients with zzso disease zzso African-American patients and 146 white zzso were recruited from the Duke Cancer Clinic and from Duke Oncology zzso zzso zzso Patients were interviewed using a standardized zzso Questions included patients' knowledge of cancer, zzso beliefs, satisfaction with medical care, knowledge of clinical trials, reasons for participating or refusing to participate in a clinical trial, zzso issues, and demographic factors, such as age and zzso Data on attitudes and belief were analyzed for group differences between African-American patients and white patients as well as between patients who were treated at the Duke Cancer Clinic and patients who were treated at zzso zzso 

zzso to participate in a clinical trial depended on both race and clinic zzso zzso percent of white patients, compared with zzso of African-American patients, were willing to participate in a clinical trial zzso zzso zzso white and African-American patients who were treated at the Duke Cancer Clinic were more willing to participate in a trial compared with their counterparts who were treated at zzso clinics zzso zzso zzso zzso P zzso zzso The greatest differences between groups zzso patients zzso white patients and Duke Cancer Clinic patients zzso zzso zzso were education and zzso Much greater percentages of African-American patients and zzso patients did not complete high school and had annual incomes zzso zzso In addition, more African-American patients than white patients believed that God would determine whether they would be cured or would die from their zzso In a zzso analysis, education, income, and belief that God would determine the patient's outcome also were correlated with a decreased willingness to participate in clinical zzso 

zzso associated with religion, education, and income, rather than race, may be major barriers to clinical trial zzso zzso that target education and income may increase the recruitment of African-American zzso patients onto clinical zzso 

